MedPath

University Hospital Heidelberg

University Hospital Heidelberg logo
🇩🇪Germany
Ownership
Private
Established
1388-01-01
Employees
-
Market Cap
-
Website
https://www.klinikum.uni-heidelberg.de/Startseite.2.0.html?&no_cache=1

Clinical Trials

168

Active:10
Completed:69

Trial Phases

4 Phases

Phase 1:10
Phase 2:21
Phase 3:4
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (106 trials with phase data)• Click on a phase to view related trials

Not Applicable
71 (67.0%)
Phase 2
21 (19.8%)
Phase 1
10 (9.4%)
Phase 3
4 (3.8%)

Is Mentalization-based Therapy More Effective Than Treatment-as-usual for Adolescents With Dissocial Disorders?

Not Applicable
Not yet recruiting
Conditions
Conduct Disorders in Adolescence
Oppositional Defiant Disorder
First Posted Date
2025-09-18
Last Posted Date
2025-09-18
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
90
Registration Number
NCT07181928
Locations
🇩🇪

Institut für Psychosoziale Prävention, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Baden-Wurttemberg, Germany

Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients

Not Applicable
Recruiting
Conditions
Multiple Myeloma
Balance Training Effects
Fall Risk Factors
Strength Training Effects
First Posted Date
2025-07-01
Last Posted Date
2025-07-01
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
60
Registration Number
NCT07044427
Locations
🇩🇪

University Hospital Heidelberg, Heidelberg, Baden Würtemberg, Germany

Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy

Not Applicable
Active, not recruiting
Conditions
Multiple Myeloma Bone Lesions
First Posted Date
2025-06-18
Last Posted Date
2025-06-18
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
50
Registration Number
NCT07026799
Locations
🇩🇪

Heidelberg University Hospital - GMMG Study Group, Heidelberg, Germany

Partial Breast Re-irradiation for Breast Cancer

Phase 2
Recruiting
Conditions
Breast Cancers
First Posted Date
2025-05-01
Last Posted Date
2025-09-02
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
20
Registration Number
NCT06954623
Locations
🇩🇪

University Hospital Heidelberg, Department Radiation Oncology, Heidelberg, Germany

DV 100 as a Framework for the Hospital Incident Command System

Recruiting
Conditions
Disaster
Crisis Response Plan
Emergency
Communication
First Posted Date
2025-04-06
Last Posted Date
2025-07-11
Lead Sponsor
University Hospital Heidelberg
Target Recruit Count
20
Registration Number
NCT06913010
Locations
🇩🇪

University Hospital Heidelberg, Heidelberg, Germany

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 34
  • Next

News

iMDx Digital PCR Platform Shows Equivalent Performance to NGS in Kidney Transplant Rejection Testing

iMDx's digital PCR-based GraftAssureIQ test demonstrated equivalent donor-derived cell-free DNA measurements compared to next-generation sequencing platforms in a head-to-head study of 96 kidney transplant recipients.

Long-term Data Shows No Survival Advantage for Salvage Transplant vs. Lenalidomide in Relapsed Multiple Myeloma

Phase 3 GMMG ReLApsE trial reveals salvage transplantation plus lenalidomide/dexamethasone did not significantly improve survival compared to lenalidomide/dexamethasone alone in relapsed multiple myeloma patients.

HDP-101 Shows Promise in Relapsed/Refractory Multiple Myeloma

HDP-101, a novel BCMA-targeting antibody-drug conjugate, demonstrates encouraging efficacy in heavily pretreated multiple myeloma patients.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.